🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

AFFLE vs EXPLEOSOL: Stock Comparison

AFFLE 3I vs EXPLEO SOLUTIONSUpdated 30 Oct 26, 4:08 PM ISTNSE & company filings

AFFLE 3I is the larger company by market capitalisation. AFFLE 3I shows faster revenue growth and a higher net margin, while EXPLEO SOLUTIONS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AFFLE leads 3; EXPLEOSOL leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AFFLEEXPLEOSOL

Valuation lens

What price are you paying?

Market CapContext only
₹18,948 Cr
₹1,249 Cr
P/E RatioEXPLEOSOL has the lower reading
39.62x
9.06x ✓
P/B RatioEXPLEOSOL has the lower reading
5.18x
1.61x ✓
EPSEXPLEOSOL has the higher reading
₹33.86
₹88.75 ✓
Book ValueContext only
₹260.06
₹500.21
Dividend YieldEXPLEOSOL has the higher reading
0%
13.75% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
AFFLE is the larger company
₹18,948 Cr vs ₹1,249 Cr
P/E Ratio
EXPLEOSOL has a lower P/E
9.06x vs 39.62x
P/B Ratio
EXPLEOSOL has a lower P/B
1.61x vs 5.18x
EPS
EXPLEOSOL has higher earnings per share
₹88.75 vs ₹33.86
Dividend Yield
EXPLEOSOL has a higher dividend yield
13.75% vs 0%
Revenue Growth (TTM YoY)
AFFLE has faster revenue growth
20.3% vs 11.9%
EPS Growth (TTM YoY)
EXPLEOSOL has faster EPS growth
73.2% vs 15.7%
ROE
EXPLEOSOL has a higher ROE
15% vs 12.45%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAFFLEEXPLEOSOL
SectorInformation TechnologyInformation Technology
IndustryIT Enabled ServicesIT Enabled Services

Price

MetricAFFLEEXPLEOSOL
Live Price₹1,341.8₹801.4
Day Change-2.86%-1.94%
Volume1.09 L14,270
52-Week High₹1,960.2₹1,175.1
52-Week Low₹1,251.3₹640
Distance from 52W High-31.55%-31.8%

Valuation

MetricAFFLEEXPLEOSOL
Market Cap₹18,948 Cr₹1,249 Cr
P/E Ratio39.62x9.06x
P/B Ratio5.18x1.61x
EPS₹33.86₹88.75
Book Value₹260.06₹500.21
Dividend Yield0%13.75%

Growth

MetricAFFLEEXPLEOSOL
Revenue Growth (TTM YoY)20.3%11.9%
EPS Growth (TTM YoY)15.7%73.2%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricAFFLEEXPLEOSOL
ROE12.45%15%
ROCE18.54%29.61%
Net Margin16.79%11.19%
Operating Margin20.81%14.38%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricAFFLEEXPLEOSOL
Promoter Holding0%71.05%
FII Holding14.6%▼ 0.78 pp0.16%▲ 0.03 pp
DII Holding19.16%▲ 0.38 pp0.39%▲ 0.27 pp
Public Holding11.2%▲ 0.38 pp28.4%▼ 0.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AFFLE 3I and EXPLEO SOLUTIONS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.